Therapeutic Effects of 7- to 14-Day Subanesthetic Ketamine Infusions for Chronic Pain on Standardized Psychiatric Measures

References

• Noppers I , NiestersM , AartsL , SmithT , SartonE , DahanA. Ketamine for the treatment of chronic non-cancer pain. Expert Opin. Pharmacother.11(14), 2417–2429 (2010).
   PubMed Web of Science ®Google Scholar
• Zhao J , WangY , WangD. The effect of ketamine infusion in the treatment of complex regional pain syndrome: a systemic review and meta-analysis. Curr. Pain Headache Rep.22(2), 12 (2018).
   PubMed Web of Science ®Google Scholar
• Orhurhu V , OrhurhuMS , BhatiaA , CohenSP. Ketamine infusions for chronic pain: a systematic review and meta-analysis of randomized controlled trials. Anesth. Analg.129(1), 241–254 (2019).
   PubMed Web of Science ®Google Scholar
• Balachandran A , TassoneVK , AdamsahibFet al. Efficacy of ketamine for comorbid depression and acute or chronic pain: a systematic review. Front. Pain Res.3, 1022767 (2022).
   Google Scholar
• Tully JL , DahlénAD , HaggartyCJ , SchiöthHB , BrooksS. Ketamine treatment for refractory anxiety: a systematic review. Br. J. Clin. Pharmacol.88(10), 4412–4426 (2022).
   PubMed Web of Science ®Google Scholar
• Marcantoni WS , AkoumbaBS , WassefMet al. A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 – January 2019. J. Affect. Disord.277, 831–841 (2020).
   PubMed Web of Science ®Google Scholar
• Tran K , McCormackS. Ketamine for Chronic Non-Cancer Pain: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines.Canadian Agency for Drugs and Technologies in Health, Ottawa, Canada (2020). www.ncbi.nlm.nih.gov/books/NBK564230/
   Google Scholar
• Pereira FG , FrançaMH , PaivaMCA , AndradeLH , VianaMC. Prevalence and clinical profile of chronic pain and its association with mental disorders. Rev. Saude Publica51, 96 (2017).
   PubMed Web of Science ®Google Scholar
• Chebini A , MarzoughiS , RandhawaJet al. The effects of a multiday (10–14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain. Pain Manag.12(3), 337–346 (2022).
   PubMed Web of Science ®Google Scholar
• Rayner L , HotopfM , PetkovaH , MatchamF , SimpsonA , McCrackenLM. Depression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costs. Pain157(7), 1472–1479 (2016).
   PubMed Web of Science ®Google Scholar
• Falk E , SchlieperD , van CasterPet al. A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study. BMC Palliat. Care19(1), 1 (2020).
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration . Orphan drug designations and approvals: ketamine (2022). www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=883122
   Google Scholar
• Maher DP , ChenL , MaoJ. Intravenous ketamine infusions for neuropathic pain management: a promising therapy in need of optimization. Anesth. Analg.124(2), 661–674 (2017).
   PubMed Web of Science ®Google Scholar
• Tan G , JensenMP , ThornbyJI , ShantiBF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J. Pain5(2), 133–137 (2004).
   PubMed Web of Science ®Google Scholar
• Kroenke K , SpitzerRL , WilliamsJB. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med.16(9), 606–613 (2001).
   PubMed Web of Science ®Google Scholar
• Seo JG , ParkSP. Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. J. Headache Pain16, 65 (2015).
   PubMed Web of Science ®Google Scholar
• Löwe B , DeckerO , MüllerSet al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med. Care46(3), 266–274 (2008).
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP , von ElmE , AltmanDGet al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLOS Med.4(10), e297 (2007).
   PubMed Web of Science ®Google Scholar
• Mease PJ , SpaethM , ClauwDJet al. Estimation of minimum clinically important difference for pain in fibromyalgia. Arthritis Care Res.63(6), 821–826 (2011).
   PubMed Web of Science ®Google Scholar
• Dworkin RH , TurkDC , WyrwichKWet al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J. Pain9(2), 105–121 (2008).
   PubMed Web of Science ®Google Scholar
• Löwe B , UnützerJ , CallahanCM , PerkinsAJ , KroenkeK. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med. Care42(12), 1194–1201 (2004).
   PubMed Web of Science ®Google Scholar
• Toussaint A , HüsingP , GumzAet al. Sensitivity to change and minimal clinically important difference of the 7-item Generalized Anxiety Disorder Questionnaire (GAD-7). J. Affect. Disord.265, 395–401 (2020).
   PubMed Web of Science ®Google Scholar
• Tiger M , VeldmanER , EkmanCJ , HalldinC , SvenningssonP , LundbergJ. A randomized placebo-controlled PET study of ketamine’s effect on serotonin1B receptor binding in patients with SSRI-resistant depression. Transl. Psychiatry10(1), 159 (2020).
   PubMed Web of Science ®Google Scholar
• Pastrak M , Abd-ElsayedA , MaF , VroomanB , VisnjevacO. Systematic review of the use of intravenous ketamine for fibromyalgia. Ochsner J.21(4), 387–394 (2021).
   PubMed Web of Science ®Google Scholar
• Zanicotti CG , PerezD , GlueP. Mood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancer. J. Palliat. Med.15(4), 400–403 (2012).
   PubMed Web of Science ®Google Scholar
• Amin P , RoelandE , AtayeeR. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain. J. Pain Palliat. Care Pharmacother.28(3), 233–242 (2014).
   PubMedGoogle Scholar
• Zekry O , GibsonSB , AggarwalA. Subanesthetic, subcutaneous ketamine infusion therapy in the treatment of chronic nonmalignant pain. J. Pain Palliat. Care Pharmacother.30(2), 91–98 (2016).
   PubMed Web of Science ®Google Scholar